Envue Medical Inc.
13F holders, Q2 2026 (June 30)13holders
5new positions
6sold out
$0.51avg. 13F price*
At the end of Q2 2026, 13 institutions reported holding Envue Medical Inc. in their 13F filings, unchanged from Q1 2026. 5 opened new positions and 6 sold out. The largest holders were HRT Financial LP ($59K), Virtu Financial LLC ($49K) and Jane Street Group, LLC ($19K).
- Company
- Envue Medical Inc.
- CUSIP
- 63008J884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $133K |
| Exits | 6 | $95K |
All 13F filers, Q1 2026 → Q2 2026: 260,752 shares bought and 50,844 shares sold, net +209,908 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| HRT Financial LP | 0.00% | New | 115,579 | $59K |
| Virtu Financial LLC | 0.00% | New | 95,296 | $49K |
| Jane Street Group, LLC | 0.00% | New | 37,635 | $19K |
| Geode Capital Management, LLC | 0.00% | Reduce -31.0% | 15,466 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 10,279 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 10,000 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +69.6% | 4,781 | $2K |
| Global Retirement Partners, LLC | 0.00% | — | 1,600 | $824 |
| Vanguard Capital Management LLC | 0.00% | No change | 189 | $97 |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 85 | $44 |
| Wells Fargo & Company | 0.00% | No change | 45 | $23 |
| SBI Securities Co., Ltd. | 0.00% | No change | 15 | $8 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is ENVUE MEDICAL INC.'s weight in each manager's 13F, not the share of Envue Medical Inc. the manager owns.